BACE1 inhibitors (Columbia Technology Ventures/Columbia University)

N/A

Report date: 2025/03/17 20:00:36
NME

Base Information

Drug NameBACE1 inhibitors (Columbia Technology Ventures/Columbia University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-secretase 1 inhibitors
TargetsBeta-secretase 1
Therapy Area/IndicationsNerve DegenerationAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesColumbia Technology VenturesColumbia University
Active IndicationsN/A
Inactive IndicationsNerve DegenerationAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A